Effectiveness of COVID-19 mRNA vaccination for children and adolescents confirmed by multi-state study

A multi-state study from the Centers for Disease Control and Prevention’s (CDC’s) VISION Network confirms that the Pfizer-BioNTech mRNA COVID-19 vaccine has provided children and adolescents, ages 5-17, with protection against both moderate and severe COVID-19 outcomes.

Leave A Comment

Your email address will not be published. Required fields are marked *